How do you actually stack BPC-157 and TB-500 for recovery?
Standard community recovery stack: 250 mcg BPC-157 sub-q daily plus 2 mg TB-500 sub-q twice weekly for 4 to 6 weeks loading, then BPC-157 at 3 to 4 times weekly plus TB-500 once weekly for another 4 to 6 weeks. The combination is plausible and widely run; not formally trialled.
Last reviewed · Panya.health editorial
Why people combine them
BPC-157 promotes angiogenesis and modulates nitric oxide in injured tissue. TB-500 promotes cell migration and actin polymerization. The community framing is that BPC-157 builds the supply chain (vessels), TB-500 moves the workforce (cells). Both work on overlapping but distinct healing pathways, which is the rationale for combining them.
Standard community-practice protocol
Loading phase: 250 mcg BPC-157 daily plus 2 mg TB-500 twice weekly, 4 to 6 weeks. Maintenance: same BPC-157 dose at 3 to 4 times weekly plus 2 mg TB-500 once weekly, another 4 to 6 weeks. Both compounds reconstituted in 5 mL bacteriostatic water (1 mg/mL). Sub-q injection. TB-500 has a longer half-life so systemic dosing works fine; BPC-157's shorter half-life makes peri-injury injection slightly preferred when feasible.
What to know about evidence
Animal data on each compound individually is reasonable. Pre-clinical data on the combination is sparse. No formal human trials of the stack exist. Community evidence is large but uncontrolled. Both compounds touch cell-proliferation pathways, which means active or recent cancer is a hard contraindication. Both are WADA-banned in competitive sport. Long-term human safety data does not exist for either.
Read about these peptides
BPC-157 is a synthetic 15-amino-acid peptide derived from a protein in human gastric juice. Most-studied peptide in the recovery and tendon-healing community. Not approved for human medical use anywhere; sold as a resear...
TB-500 is a synthetic fragment of thymosin beta-4, a naturally-occurring 43-amino-acid peptide. Often stacked with BPC-157 for recovery. Not approved for human use; banned in competitive sport by WADA.
Common pairings
The most common research-peptide recovery stack. BPC-157 for cytoprotection + angiogenesis; TB-500 for cell migration + actin remodeling. Combined for tendon, ligament, muscle injury.
Community gut-healing stack. BPC-157 for mucosal repair + cytoprotection; KPV for downstream anti-inflammatory cytokine modulation. Common in IBD-symptom and post-antibiotic protocols.
Related posts
The clinic route costs more and takes longer. The research-chem route puts more on you. Neither is wrong. Here is how to choose.
The five things that matter on a COA, the three things that do not, and the one question that separates a serious vendor from a cargo-cult operator.
People who asked this also asked
The tools behind the answer
The answer for your situation.
The answer above is the general case. The match for your specific profile, region, budget, and urgency comes from our 2-minute quiz. One email, your match, no list.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.